US Stock MarketDetailed Quotes
NARI Inari Medical
- 51.920
- +0.890+1.74%
Close Nov 29 13:00 ET
- 52.750
- +0.830+1.60%
Post 17:01 ET
3.04BMarket Cap-38459P/E (TTM)
51.920High50.950Low287.79KVolume51.010Open51.030Pre Close14.85MTurnover0.54%Turnover RatioLossP/E (Static)58.54MShares67.13052wk High6.99P/B2.77BFloat Cap36.73052wk Low--Dividend TTM53.43MShs Float127.420Historical High--Div YieldTTM1.90%Amplitude36.730Historical Low51.595Avg Price1Lot Size
About Inari Medical Company
Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Company Profile
SymbolNARI
Company NameInari Medical
Listing DateMay 22, 2020
Issue Price19.00
Founded2011
CEOMr. Andrew Hykes
MarketNASDAQ
Employees1300
Fiscal Year Ends12-31
Address6001 Oak Canyon,Suite 100
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-877-923-4747
Websitehttp://www.inarimedical.com
Company Executives
- Name
- Position
- Salary
- Andrew Hykes
- Director, President and Chief Executive Officer
- 5.08M
- Kevin Strange
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Thomas Tu, M.D.
- Chief Medical Officer
- 2.50M
- Donald Milder
- Chairman of the Board
- 266.43K
- William Hoffman
- Director
- 198.43K
- Dr. Jonathan D. Root,M.D.
- Independent Director
- 230.93K
- Rebecca Chambers
- Independent Director
- 220.93K
- Cynthia L. Lucchese
- Independent Director
- 235.93K
- Dana G. Mead, Jr
- Independent Director
- 218.43K
- Catherine M. Szyman
- Independent Director
- 220.47K
- Robert Warner
- Independent Director
- 220.93K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data